International KPD Report Saudi Arabia King Faisal Specialist Hospital & Research Center, Riyadh, Single Center Program
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
|
|---|---|---|---|---|---|---|
| KPD Transplanted Pair Types | ||||||
| HLA Incompatible | 0 | 0 | 15 | 25 | 26 | 22 |
| ABO Incompatible | 0 | 0 | 3 | 5 | 6 | 6 |
| HLA & ABO Incompatible | 0 | 0 | 0 | 2 | 4 | 2 |
| Compatible (HLA & ABO) | 0 | 0 | 8 | 12 | 10 | 7 |
| Subtotal | 0 | 0 | 26 | 44 | 46 | 37 |
| Chain Ends (Patients without donors) | 0 | 0 | 0 | 1 | 0 | 0 |
| Total | 0 | 0 | 26 | 45 | 46 | 37 |
| Chronologically Incompatible | N/A | N/A | N/A | N/A | N/A | N/A |
| KPD Transplanted Pair Types As % of TXPs | ||||||
| HLA Incompatible | N/A | N/A | 58% | 57% | 57% | 59% |
| ABO Incompatible | N/A | N/A | 12% | 11% | 13% | 16% |
| HLA & ABO Incompatible | N/A | N/A | 0% | 5% | 9% | 5% |
| Compatible (HLA & ABO) | N/A | N/A | 31% | 27% | 22% | 19% |
| KPD Enrollments | ||||||
| HLA Incompatible | 0 | 0 | 30 | 45 | 49 | 51 |
| ABO Incompatible | 0 | 0 | 4 | 12 | 8 | 9 |
| HLA & ABO Incompatible | 0 | 0 | 2 | 4 | 4 | 2 |
| Compatible (HLA & ABO) | 0 | 0 | 10 | 13 | 12 | 9 |
| Subtotal | 0 | 0 | 46 | 74 | 73 | 71 |
| Chain Ends (Patients without donors) | 0 | 0 | N/A | N/A | N/A | 0 |
| Total | 0 | 0 | 46 | 74 | 73 | 71 |
| Chronologically Incompatible | N/A | N/A | N/A | N/A | N/A | N/A |
| KPD TXPs as % of Enrollments | ||||||
| HLA Incompatible | N/A | N/A | 50% | 56% | 53% | 43% |
| ABO Incompatible | N/A | N/A | 75% | 42% | 75% | 67% |
| HLA & ABO Incompatible | N/A | N/A | 0% | 50% | 100% | 100% |
| Compatible (HLA & ABO) | N/A | N/A | 80% | 92% | 83% | 78% |
| Chain Ends (Patients without donors) | N/A | N/A | N/A | N/A | N/A | N/A |
| Total | N/A | N/A | 57% | 61% | 63% | 52% |
| Chronologically Incompatible | N/A | N/A | N/A | N/A | N/A | N/A |
| KPD Transplants by CPRA | ||||||
| 0% | 0 | 0 | 9 | 11 | 8 | 11 |
| > 0% - < 80% | 0 | 0 | 6 | 11 | 17 | 4 |
| 80%+ | 0 | 0 | 11 | 22 | 21 | 22 |
| Total | 0 | 0 | 26 | 44 | 46 | 37 |
| % KPD Transplants by CPRA | ||||||
| 0% | N/A | N/A | 35% | 25% | 17% | 30% |
| > 0% - < 80% | N/A | N/A | 23% | 25% | 37% | 11% |
| 80%+ | N/A | N/A | 42% | 50% | 46% | 59% |
| KPD Transplants by Type | ||||||
| Desensitization | 0 | 0 | 7 | 7 | 5 | 9 |
| ABO Incompatible | 0 | 0 | 1 | 4 | 5 | 6 |
| A2 -> O/B w/ acceptable titers | 0 | 0 | 0 | 2 | 1 | 2 |
| Total | 0 | 0 | 8 | 13 | 11 | 17 |
| Cluster Starters | ||||||
| NDDs | 0 | 0 | 0 | 1 | 0 | 0 |
| Voucher Donors | 0 | 0 | 0 | 0 | 0 | 0 |
| Family | N/A | N/A | N/A | N/A | N/A | N/A |
| Standard | N/A | N/A | N/A | N/A | N/A | N/A |
| Swap Savers | N/A | N/A | N/A | N/A | N/A | N/A |
| Real-Time Swap Failure | N/A | N/A | N/A | N/A | N/A | N/A |
| Bridge Donors | 0 | 0 | 0 | 1 | 0 | 0 |
| Total | 0 | 0 | 0 | 2 | 0 | 0 |